全文获取类型
收费全文 | 1670篇 |
免费 | 93篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 13篇 |
妇产科学 | 8篇 |
基础医学 | 285篇 |
口腔科学 | 37篇 |
临床医学 | 100篇 |
内科学 | 550篇 |
皮肤病学 | 24篇 |
神经病学 | 93篇 |
特种医学 | 26篇 |
外科学 | 302篇 |
综合类 | 1篇 |
预防医学 | 46篇 |
眼科学 | 9篇 |
药学 | 77篇 |
中国医学 | 6篇 |
肿瘤学 | 203篇 |
出版年
2023年 | 11篇 |
2022年 | 30篇 |
2021年 | 54篇 |
2020年 | 29篇 |
2019年 | 30篇 |
2018年 | 43篇 |
2017年 | 34篇 |
2016年 | 37篇 |
2015年 | 31篇 |
2014年 | 32篇 |
2013年 | 40篇 |
2012年 | 90篇 |
2011年 | 72篇 |
2010年 | 59篇 |
2009年 | 48篇 |
2008年 | 73篇 |
2007年 | 74篇 |
2006年 | 68篇 |
2005年 | 63篇 |
2004年 | 62篇 |
2003年 | 78篇 |
2002年 | 52篇 |
2001年 | 66篇 |
2000年 | 62篇 |
1999年 | 51篇 |
1998年 | 28篇 |
1997年 | 17篇 |
1996年 | 7篇 |
1995年 | 12篇 |
1994年 | 13篇 |
1993年 | 13篇 |
1992年 | 65篇 |
1991年 | 44篇 |
1990年 | 41篇 |
1989年 | 40篇 |
1988年 | 26篇 |
1987年 | 28篇 |
1986年 | 30篇 |
1985年 | 19篇 |
1984年 | 10篇 |
1983年 | 9篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1977年 | 8篇 |
1975年 | 5篇 |
1974年 | 5篇 |
1973年 | 6篇 |
1970年 | 7篇 |
1968年 | 6篇 |
1966年 | 8篇 |
排序方式: 共有1786条查询结果,搜索用时 15 毫秒
91.
Masayuki Shimojima Atsushi Takenouchi Hiroshi Shimoda Naho Kimura Ken Maeda 《Archives of virology》2014,159(8):2023-2031
Infection with West Nile virus and dengue virus, two mosquito-borne flaviviruses, is enhanced by two calcium-dependent lectins: dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), and its related molecule (DC-SIGNR). The present study examined the relationship between Japanese encephalitis virus (JEV) infection and three lectins: DC-SIGN, DC-SIGNR, and liver sinusoidal endothelial cell lectin (LSECtin). Expression of DC-SIGNR resulted in robust JEV proliferation in a lymphoid cell line, Daudi cells, which was otherwise non-permissive to infection. DC-SIGN expression caused moderate JEV proliferation, with effects that varied according to the cells in which JEV was prepared. LSECtin expression had comparatively minor, but consistent, effects, in all cell types used in JEV preparation. While DC-SIGN/DC-SIGNR-mediated JEV infection was inhibited by yeast mannan, LSECtin-mediated infection was inhibited by N-acetylglucosamine β1-2 mannose. Although involvement of DC-SIGN/DC-SIGNR in infection seems to be a common characteristic, this is the first report on usage of LSECtin in mosquito-borne flavivirus infection. 相似文献
92.
Control of expression of Agrobacterium vir genes by synergistic actions of phenolic signal molecules and monosaccharides 总被引:26,自引:1,他引:26 下载免费PDF全文
Shimoda N Toyoda-Yamamoto A Nagamine J Usami S Katayama M Sakagami Y Machida Y 《Proceedings of the National Academy of Sciences of the United States of America》1990,87(17):6684-6688
Most virulence (vir) genes of Agrobacterium tumefaciens that are required for the formation of crown gall tumors are expressed in response to such plant signal molecules as acetosyringone and lignin precursors. The phenolic signals are transduced through a receptor VirA protein in the inner membrane of the bacterial cell. The expression of these genes triggers the transfer of a specific DNA segment, called transferred DNA (T-DNA), from the Ti plasmid to plant cells, and its integration into their nuclear DNA. We show here that a group of aldoses (L-arabinose, D-xylose, D-lyxose, D-glucose, D-mannose, D-idose, D-galactose, and D-talose) can markedly enhance acetosyringone-dependent expression of vir genes when the concentration of acetosyringone is limited (10 microM) but does not enhance the expression of noninducible genes. Likewise, a 2-deoxy-D-glucose, a nonmetabolized sugar, is also effective. When a deletion was introduced into the virA gene in the region encoding the periplasmic portion of the VirA protein, enhancement by glucose disappeared, but vir expression was induced by acetosyringone in this mutant. These results suggest that these sugars directly enhance a signaling process initiated by phenolic inducers that results in an increase in expression of the vir genes. 相似文献
93.
Yukino Katakura Fuminori Tatsumi Takashi Kusano Masashi Shimoda Kenji Kohara Tomohiko Kimura Atsushi Obata Shuhei Nakanishi Tomoatsu Mune Kohei Kaku Hideaki Kaneto 《Internal medicine (Tokyo, Japan)》2022,61(6):861
A 58-year-old Japanese man was brought to the emergency room due to disturbance of consciousness. He regained consciousness on the day of admission and started taking hospital meals, but he needed intravenous glucose administration for eight days. The total amount of glucose administration was 4,464 g. It took over three weeks for exogenous insulin to be almost undetectable. While degludec binds to albumin and exerts glucose-lowering effects for a long time, the above-mentioned period of three weeks was consistent with the half-life of albumin. Hypoglycemia induced by massive dose of insulin degludec is persistent and prominent. 相似文献
94.
Terufumi Shimoda Hiroshi Odajima Arisa Okamasa Minako Kawase Masaki Komatsubara Bhabita Mayer Steven Yancey Hector Ortega 《Allergology international》2017,66(3):445-451
Background
The MENSA trial assessed the efficacy and safety of mepolizumab in patients with severe eosinophilic asthma. This report describes the efficacy and safety of mepolizumab in Japanese patients from MENSA.Methods
A post hoc analysis of the Japanese subgroup from the randomized, double-blind, placebo-controlled, double-dummy, Phase III MENSA trial (NCT01691521). Patients ≥12 years with severe eosinophilic asthma received mepolizumab 75 mg intravenously (IV), 100 mg subcutaneously (SC), or placebo, every 4 weeks for 32 weeks. The primary endpoint was the annualized rate of exacerbations. Secondary and other endpoints included annualized rate of exacerbations requiring emergency department (ED) visit/hospitalization, morning peak expiratory flow (PEF), St George's Respiratory Questionnaire (SGRQ) score and eosinophil counts. Adverse events (AEs) were monitored.Results
In the Japanese subgroup (N = 50), the rate of clinically significant exacerbations was reduced by 90% (rate ratio [RR]: 0.10; 95% confidence interval [CI]: 0.02–0.57; P = 0.010) with mepolizumab IV and 62% (RR: 0.38; 95% CI: 0.12–1.18; P = 0.094) with mepolizumab SC, versus placebo. No exacerbations requiring ED visit/hospitalization were reported with mepolizumab IV; exacerbations were reduced by 73% (RR: 0.27; 95% CI: 0.06–1.29; P = 0.102) with mepolizumab SC versus placebo. Compared with placebo, mepolizumab IV and SC numerically increased morning PEF from baseline by 40 L/min and 13 L/min, improved quality of life by greater than the minimal clinically important difference (SGRQ: 9.5 [P = 0.083] and 7.9 [P = 0.171] points) and reduced eosinophil counts. AE incidence was similar between treatments. Results were broadly consistent with the overall population.Conclusions
Mepolizumab was efficacious and well tolerated in Japanese patients with severe eosinophilic asthma, producing similar responses to the overall MENSA population. 相似文献95.
96.
97.
Vassiliki A. Papadimitrakopoulou MD Ji-Youn Han MD PhD Myung-Ju Ahn MD PhD Suresh S. Ramalingam MD Angelo Delmonte MD PhD Te-Chun Hsia MD Janessa Laskin MD Sang-We Kim MD PhD Yong He MD Chun-Ming Tsai MD Toyoaki Hida MD PhD Makoto Maemondo MD PhD Terufumi Kato MD Suzanne Jenkins DPhil Sabina Patel PhD Xiangning Huang PhD Gianluca Laus MD Aleksandra Markovets PhD Kenneth S. Thress PhD Yi-Long Wu MD Tony Mok MD 《Cancer》2020,126(2):373-380
98.
Takeshi Nagashima Ken Yamaguchi Kenichi Urakami Yuji Shimoda Sumiko Ohnami Keiichi Ohshima Tomoe Tanabe Akane Naruoka Fukumi Kamada Masakuni Serizawa Keiichi Hatakeyama Kenya Matsumura Shumpei Ohnami Koji Maruyama Tohru Mochizuki Masatoshi Kusuhara Akio Shiomi Yasuhisa Ohde Masanori Terashima Katsuhiko Uesaka Tetsuro Onitsuka Seiichiro Nishimura Yasuyuki Hirashima Nakamasa Hayashi Yoshio Kiyohara Yasuhiro Tsubosa Hirohisa Katagiri Masashi Niwakawa Kaoru Takahashi Hiroya Kashiwagi Masahiro Nakagawa Yuji Ishida Takashi Sugino Mitsuru Takahashi Yasuto Akiyama 《Cancer science》2020,111(2):687-699
This study aimed to establish the Japanese Cancer Genome Atlas (JCGA) using data from fresh frozen tumor tissues obtained from 5143 Japanese cancer patients, including those with colorectal cancer (31.6%), lung cancer (16.5%), gastric cancer (10.8%) and other cancers (41.1%). The results are part of a single‐center study called “High‐tech Omics‐based Patient Evaluation” or “Project HOPE” conducted at the Shizuoka Cancer Center, Japan. All DNA samples and most RNA samples were analyzed using whole‐exome sequencing, cancer gene panel sequencing, fusion gene panel sequencing and microarray gene expression profiling, and the results were annotated using an analysis pipeline termed “Shizuoka Multi‐omics Analysis Protocol” developed in‐house. Somatic driver alterations were identified in 72.2% of samples in 362 genes (average, 2.3 driver events per sample). Actionable information on drugs that is applicable in the current clinical setting was associated with 11.3% of samples. When including those drugs that are used for investigative purposes, actionable information was assigned to 55.0% of samples. Germline analysis revealed pathogenic mutations in hereditary cancer genes in 9.2% of samples, among which 12.2% were confirmed as pathogenic mutations by confirmatory test. Pathogenic mutations associated with non–cancerous hereditary diseases were detected in 0.4% of samples. Tumor mutation burden (TMB) analysis revealed 5.4% of samples as having the hypermutator phenotype (TMB ≥ 20). Clonal hematopoiesis was observed in 8.4% of samples. Thus, the JCGA dataset and the analytical procedures constitute a fundamental resource for genomic medicine for Japanese cancer patients. 相似文献
99.
Nagashima T Ichimiya S Kikuchi T Saito Y Matsumiya H Ara S Koshiba S Zhang J Hatate C Tonooka A Kubo T Ye RC Hirose B Shirasaki H Izumi T Takami T Himi T Sato N 《The American journal of pathology》2011,178(1):222-232
In this study, we report the unique role of arachidonate 5-lipoxygenase (Alox5) in the regulation of specific humoral immune responses. We previously reported an L22 monoclonal antibody with which human primary resting B cells in the mantle zones of lymphoid follicles are well-defined. Proteomics analyses enabled identification of an L22 antigen as Alox5, which was highly expressed by naive and memory B cells surrounding germinal centers. Cellular growth of mantle cell lymphoma cells also seemed to depend on Alox5. Alox5(-/-) mice exhibited weak antibody responses specific to foreign antigens at the initial and recall phases. This was probably attributable to the low number of follicular and memory B cells and the functional loss of interleukin-21-mediated responses of follicular B cells. Moreover, Alox5(-/-) mice could not fully foster the development of follicular B helper T (Tfh) cells even after immunization with foreign antigens. Further experiments indicated that Alox5 affected mortality in experimentally induced enterocolitis in germ-prone circumstances, indicating that Alox5 would endow immunologic milieu. Our results illustrate the novel role of Alox5 in adaptive humoral immunity by managing primary B cells and Tfh cells in vivo. 相似文献
100.
Masaki Miyahara Takao Saito Kaoru Etoh Katsuhiro Shimoda Seigo Kitano Michio Kobayashi Shigeo Yokoyama 《Surgery today》1995,25(9):834-837
A 40-year-old woman with Peutz-Jeghers syndrome and an appendiceal intussusception is reported. In this patient, the lead point was a large sessile, appendiceal polyp. The invaginated and inverted portion of the appendix resembled the long stalk of a pedunculated polyp on roentgenography and endoscopic examination. Histologically, the appendiceal polyp was a villous adenoma with mild to severe atypia and focal carcinoma in situ. In patients with Peutz-Jeghers syndrome, hamartomatous polyps and colorectal adenomatous polyps with highly malignant potential can coexist and must be managed appropriately. Therefore, when evaluating a polypoid or a pedunculated lesion in the cecal lumen, the possibility of an appendiceal intussusception should also be investigated. 相似文献